Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol ER in Osteoarthritis of the Knee and/or Hip
NCT00348452Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Sep 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of tramadol in osteoarthritis (OA) (5 arms), sponsored by Valeant Pharmaceuticals. Primary endpoints: WOMAC OA Index pain subscale score at 12 weeks, WOMAC OA Index physical function subscale score at 12 weeks and 1 more. Started Sep 2002; status: completed.
02
Drugs
tramadol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00348452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348452.